<!DOCTYPE html>
<html lang="en-us"><head>
  <meta charset="utf-8" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
   <meta name="description" content="Useful material
https://www.cellsignal.com/pathways/immune-cell-markers-human
[[Immune-Cell-Markers-Human 1.pdf]]
[[janeways-immunobiology-9th-edition_compress.pdf]]

Immune system - Lecture A
[[Lecture A]]

Cytokines = affect the behavior of immune cells, they are called interleukins when produced by lymphocytes
Chemokines = simulate the migration and activation of cells

Immune Cells
!
All Immune cells arise from one pluripotent hematopoietic bone marrow stem cell.
Ex

Monocytes - circulate in the blood stream and differentiate into macrophages in tissue
Mast cells - related to allergy response

Innate vs Adaptive immune system
Somewhat arbitrary distinction.">  

  <title>
    
      Immunotechnology
    
  </title>


  <link rel="shortcut icon" type="image/x-icon" href="/" />
  
  
  
  <link rel="stylesheet" href="/css/main.51652302d3a998bf7887aed5c2cf89141bbebdf45a2c8f87b0717a3cf4f51c4e53c694c328fb1de78c3a625a1c01f80745bf1f2f42c040647a245cbbb6c2d1d7.css" integrity="sha512-UWUjAtOpmL94h67Vws&#43;JFBu&#43;vfRaLI&#43;HsHF6PPT1HE5TxpTDKPsd54w6YlocAfgHRb8fL0LAQGR6JFy7tsLR1w==" />
   <script>
  MathJax = {
    tex: {
      inlineMath: [['$', '$'], ['\\(', '\\)']],
      displayMath: [['$$','$$'], ['\\[', '\\]']],
      processEscapes: true,
      processEnvironments: true
    },
    options: {
      skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
    }
  };

  window.addEventListener('load', (event) => {
      document.querySelectorAll("mjx-container").forEach(function(x){
        x.parentElement.classList += 'has-jax'})
    });

</script>
<script src="https://cdnjs.cloudflare.com/polyfill/v3/polyfill.min.js?features=es6"></script>
<script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
 
</head>
<body a="auto">
        <main class="page-content" aria-label="Content">
            <div class="w">
<a href="/">..</a>


<article>
    <p class="post-meta">
        <time datetime="2024-01-01 00:00:00 &#43;0000 UTC">
            2024-01-01
        </time>
    </p>

    <h1>Immunotechnology</h1>

    
        <aside >
            <nav id="TableOfContents">
  <ul>
    <li><a href="#immune-cells">Immune Cells</a></li>
    <li><a href="#innate-vs-adaptive-immune-system">Innate vs Adaptive immune system</a>
      <ul>
        <li><a href="#innate-immune-cells">Innate immune cells</a></li>
        <li><a href="#adaptive-immune-system">Adaptive Immune system</a></li>
      </ul>
    </li>
    <li><a href="#organs-of-the-immune-system">Organs of the Immune system</a>
      <ul>
        <li><a href="#lymph-node">Lymph node</a></li>
        <li><a href="#spleen-milz">Spleen (milz)</a></li>
        <li><a href="#mucosa-associated-tissue-malt">Mucosa associated tissue (MALT)</a></li>
      </ul>
    </li>
  </ul>

  <ul>
    <li><a href="#tcr">TCR</a>
      <ul>
        <li><a href="#different-cd">Different CD</a></li>
        <li><a href="#tcr-diversity">TCR diversity</a></li>
      </ul>
    </li>
    <li><a href="#major-histocompatibility-complex--mhc-on-apc">Major histocompatibility complex -MHC on APC</a>
      <ul>
        <li><a href="#mhci">MHCI</a></li>
        <li><a href="#mhcii">MHCII</a></li>
        <li><a href="#mhc-diversity">MHC diversity</a></li>
      </ul>
    </li>
    <li><a href="#antigen-presentation">Antigen Presentation</a></li>
    <li><a href="#apc">APC</a>
      <ul>
        <li><a href="#dc">DC</a></li>
        <li><a href="#internalization-of-ag">Internalization of Ag</a></li>
        <li><a href="#ag-processing">Ag processing</a></li>
        <li><a href="#mhc-restriction">MHC restriction</a></li>
      </ul>
    </li>
    <li><a href="#ag-presentation">Ag presentation</a>
      <ul>
        <li><a href="#tc">TC</a></li>
        <li><a href="#signals">Signals</a></li>
        <li><a href="#tolerance">Tolerance</a></li>
        <li><a href="#cross-presentation">Cross presentation</a></li>
      </ul>
    </li>
    <li><a href="#effector-tc">Effector TC</a>
      <ul>
        <li></li>
      </ul>
    </li>
  </ul>

  <ul>
    <li><a href="#immoglobin">Immoglobin</a>
      <ul>
        <li><a href="#biological-effects-of-ab">Biological effects of Ab</a></li>
        <li><a href="#ab-structure">Ab structure</a></li>
        <li><a href="#ab-function">Ab function</a></li>
      </ul>
    </li>
    <li><a href="#bcr-structure">BCR structure</a></li>
    <li><a href="#bc-maturation">BC maturation</a>
      <ul>
        <li><a href="#improve-the-affinity-to-ag">Improve the affinity to Ag</a></li>
      </ul>
    </li>
    <li><a href="#ab-effector-function">Ab effector function</a>
      <ul>
        <li><a href="#pasted-image-20240322111408-1pngigg-vs-igm">[[Pasted image 20240322111408 1.png|IgG vs IgM]]</a></li>
      </ul>
    </li>
    <li><a href="#ab-production-and-memory">Ab Production and memory</a></li>
    <li><a href="#summary">Summary</a></li>
  </ul>

  <ul>
    <li><a href="#innate-immunity">Innate Immunity</a></li>
    <li><a href="#inflammation">Inflammation</a></li>
    <li><a href="#complement-system">Complement system</a></li>
    <li><a href="#production-of-soluble-mediators">Production of soluble mediators</a></li>
    <li><a href="#natural-killer-cells-nk">Natural killer cells (NK)</a></li>
    <li><a href="#adaptive-immunity">Adaptive immunity</a>
      <ul>
        <li><a href="#ab">Ab</a></li>
        <li><a href="#fcr">FCR</a></li>
        <li><a href="#tc-1">TC</a></li>
      </ul>
    </li>
    <li><a href="#summary-1">Summary</a></li>
  </ul>

  <ul>
    <li><a href="#ab-source">Ab source</a></li>
    <li><a href="#antisera">Antisera</a></li>
    <li><a href="#ab-design">Ab design</a></li>
    <li><a href="#immunogen">Immunogen</a></li>
    <li><a href="#specificity">Specificity</a></li>
  </ul>

  <ul>
    <li><a href="#hybridoma-technology">Hybridoma technology</a></li>
    <li><a href="#vaccination">Vaccination</a>
      <ul>
        <li><a href="#active-vs-passive-vaccine">Active vs Passive vaccine</a></li>
        <li><a href="#generation-of-immune-response">Generation of immune response</a></li>
        <li><a href="#types-of-vaccines">Types of vaccines</a></li>
        <li><a href="#application">Application</a></li>
        <li><a href="#herd-immunity">Herd immunity</a></li>
      </ul>
    </li>
    <li><a href="#summary-2">Summary</a></li>
  </ul>

  <ul>
    <li><a href="#analysis-of-affinity">Analysis of affinity</a></li>
    <li><a href="#analysis-of-kinetics">Analysis of Kinetics</a></li>
    <li><a href="#how-to-determine-affinity">How to determine affinity</a>
      <ul>
        <li><a href="#equilibrium-dialysis">Equilibrium dialysis</a></li>
        <li><a href="#isothermal-titration-calorimetry-itc">Isothermal titration calorimetry (ITC)</a></li>
        <li><a href="#qcm-d">QCM-d</a></li>
        <li><a href="#surface-plasmon-response-spr">Surface Plasmon Response (SPR)</a></li>
        <li><a href="#ligand-tracer">Ligand Tracer</a></li>
      </ul>
    </li>
    <li><a href="#summary-3">Summary</a></li>
  </ul>

  <ul>
    <li><a href="#common-detection-principles">Common detection principles</a>
      <ul>
        <li><a href="#radioactive-isotopes">Radioactive isotopes</a></li>
      </ul>
    </li>
    <li><a href="#competitive-vs-non-competitive-analysis">Competitive vs Non-competitive analysis</a>
      <ul>
        <li><a href="#non-competitive">Non-competitive</a></li>
        <li><a href="#competitive">Competitive</a></li>
        <li><a href="#comparison">Comparison</a></li>
      </ul>
    </li>
    <li><a href="#heterogenous-vs-homogenous-analysis">Heterogenous vs Homogenous analysis</a></li>
  </ul>

  <ul>
    <li><a href="#common-assays">Common assays</a>
      <ul>
        <li><a href="#isolation-from-whole-blood">Isolation from whole blood</a></li>
        <li><a href="#isolation-with-magnetic-beads---macs">Isolation with magnetic beads - MACS</a></li>
        <li><a href="#microscopy">Microscopy</a></li>
      </ul>
    </li>
    <li><a href="#characterization-of-lymphocyte-specificity-and-function">Characterization of lymphocyte specificity and function</a></li>
    <li><a href="#flow-cytometry">Flow Cytometry</a>
      <ul>
        <li><a href="#tandem-dyes">Tandem dyes</a></li>
        <li><a href="#analysis-of-flow-cytometry">Analysis of Flow cytometry</a></li>
        <li><a href="#viability">Viability</a></li>
        <li><a href="#compensation">Compensation</a></li>
        <li><a href="#important-factors-in-flow-cytometry">Important factors in flow cytometry</a></li>
        <li><a href="#facs---cell-sorting">FACS - Cell sorting</a></li>
        <li><a href="#application-1">Application</a></li>
      </ul>
    </li>
    <li><a href="#summary-4">Summary</a></li>
  </ul>

  <ul>
    <li><a href="#precipitation">Precipitation</a>
      <ul>
        <li><a href="#single-radial-immunodiffusion">Single radial immunodiffusion</a></li>
        <li><a href="#rocket-electrophoresis">Rocket electrophoresis</a></li>
      </ul>
    </li>
    <li><a href="#immunochromatography">Immunochromatography</a>
      <ul>
        <li><a href="#ag-chromatography-ag-fixated">Ag chromatography (Ag fixated)</a></li>
        <li><a href="#protein-a-and-b-column">Protein A and B column</a></li>
        <li><a href="#purification-with-ab-coupled-to-magnetic-beads">Purification with Ab coupled to magnetic beads</a></li>
      </ul>
    </li>
    <li><a href="#immunoblotting-techniques">Immunoblotting techniques</a></li>
    <li><a href="#agglutination-techniques">Agglutination techniques</a></li>
  </ul>

  <ul>
    <li><a href="#ab-library">Ab library</a></li>
    <li><a href="#phage">Phage</a></li>
    <li><a href="#phage-rescue">Phage rescue</a></li>
    <li><a href="#phage-display-cycle">Phage display cycle</a>
      <ul>
        <li><a href="#selection-for">Selection for</a></li>
      </ul>
    </li>
    <li><a href="#analysis-of-the-selected-binders">Analysis of the selected binders</a></li>
    <li><a href="#optimize-the-abget-better-ones">Optimize the Ab/get better ones</a></li>
    <li><a href="#application-2">Application</a></li>
    <li><a href="#summary-5">Summary</a></li>
  </ul>

  <ul>
    <li><a href="#why-use-recombinant-ab">Why use Recombinant Ab?</a></li>
    <li><a href="#humanization">Humanization</a></li>
    <li><a href="#effector-function">Effector function</a></li>
    <li><a href="#production">Production</a>
      <ul>
        <li><a href="#carbohydrates-in-ab">Carbohydrates in Ab</a></li>
      </ul>
    </li>
  </ul>

  <ul>
    <li><a href="#hypersensitivity">Hypersensitivity</a>
      <ul>
        <li><a href="#definitions-hypersensitivity">Definitions (Hypersensitivity)</a></li>
      </ul>
    </li>
    <li><a href="#closer-look-at-hypersensitivity-type-1-and-4">Closer look at Hypersensitivity type 1 and 4</a>
      <ul>
        <li><a href="#1-sensitization-effector-phase-and-late-stage">1 Sensitization, Effector phase and Late stage</a></li>
        <li><a href="#type-4-sensitization-and-elicitation-phase">Type 4 sensitization and elicitation phase</a></li>
      </ul>
    </li>
    <li><a href="#why-does-allergic-contact-dermatitis-exist">Why does Allergic contact Dermatitis exist?</a></li>
    <li><a href="#effector-cells---mast-cells">Effector cells - mast cells</a></li>
    <li><a href="#effector-cells---basophils">Effector cells - Basophils</a></li>
    <li><a href="#effector-cells-th2">Effector cells Th2</a></li>
    <li><a href="#optimal-allergen">&lsquo;Optimal&rsquo; allergen</a></li>
    <li><a href="#why-develop-an-allergy">Why develop an allergy?</a></li>
    <li><a href="#diagnosis">Diagnosis</a></li>
    <li><a href="#treatment">Treatment</a></li>
    <li><a href="#summary-6">Summary</a></li>
  </ul>

  <ul>
    <li><a href="#biomarkers">Biomarkers</a></li>
    <li><a href="#ab-ag-biding">Ab-Ag biding</a>
      <ul>
        <li><a href="#labeling">Labeling</a></li>
        <li><a href="#detection">Detection</a></li>
      </ul>
    </li>
    <li><a href="#signal-amplification">Signal amplification</a>
      <ul>
        <li><a href="#tyramide-signal-amplification-tsa">Tyramide signal amplification (TSA)</a></li>
        <li><a href="#proximity-ligation-assays-pla">Proximity ligation assays (PLA)</a></li>
      </ul>
    </li>
    <li><a href="#multiplexing">Multiplexing</a>
      <ul>
        <li><a href="#micro-array">Micro array</a></li>
      </ul>
    </li>
    <li><a href="#summary-7">Summary</a></li>
  </ul>
</nav>
        </aside>
    

    <h1 id="useful-material">Useful material</h1>
<p><a href="https://www.cellsignal.com/pathways/immune-cell-markers-human">https://www.cellsignal.com/pathways/immune-cell-markers-human</a>
[[Immune-Cell-Markers-Human 1.pdf]]
[[janeways-immunobiology-9th-edition_compress.pdf]]</p>
<hr>
<h1 id="immune-system---lecture-a">Immune system - Lecture A</h1>
<p>[[Lecture A]]</p>
<ul>
<li><strong>Cytokines</strong> = affect the behavior of immune cells, they are called interleukins when produced by lymphocytes</li>
<li><strong>Chemokines</strong> = simulate the migration and activation of cells</li>
</ul>
<h2 id="immune-cells">Immune Cells</h2>
<p>!<img src="/images/Pasted%20image%2020240508100229%201.png" alt="Image Description">
All Immune cells arise from one pluripotent hematopoietic bone marrow stem cell.
Ex</p>
<ul>
<li><strong>Monocytes</strong> - circulate in the blood stream and differentiate into macrophages in tissue</li>
<li><strong>Mast cells</strong> - related to allergy response</li>
</ul>
<h2 id="innate-vs-adaptive-immune-system">Innate vs Adaptive immune system</h2>
<p>Somewhat arbitrary distinction.</p>
<ul>
<li>innate_immune_response - first line of defense, based pattern recognition receptors that recognize foreign pattern and start a fast response</li>
<li>adaptive_immune_response - changing receptors, that evolve to defend against against changing patterns</li>
</ul>
<h3 id="innate-immune-cells">Innate immune cells</h3>
<p>Belong to the mycolate lineage</p>
<ul>
<li><strong>Macrophages</strong> and <strong>Neutrophils</strong> engulf pathogens and destroy them, where macrophages also act as APC and activate TC. Both are pro inflammatory</li>
<li><strong>Dendritic cells</strong>  - primary APC, heterogenic group from different lineages</li>
<li><strong>Eosinophil</strong> and <strong>Basophil</strong> - carry granules, which are toxins, that can be released as defense against e.g. parasites. Also involved in allergic response</li>
<li><strong>Innate lymphoid cells</strong> - amplify signals from patterns recognized by innate immune response. they are activated by cytokines (relay)</li>
<li><strong>Natural killer cells</strong> - also considered ILC, don&rsquo;t need Ag specific activation to kill cell
!<img src="/images/Pasted%20image%2020240508101423%201.png" alt="Image Description">
!<img src="/images/Pasted%20image%2020240508101447%201.png" alt="Image Description"></li>
</ul>
<h3 id="adaptive-immune-system">Adaptive Immune system</h3>
<ul>
<li><strong>Dendritic cells</strong> - bridge between innate and adaptive APC, recognize pathogen by pattern recognition receptors - activated early in the infection and ingest the pathogen to display Ag on MHCII
!<img src="/images/Pasted%20image%2020240508102913%201.png" alt="Image Description">
!<img src="/images/Pasted%20image%2020240508102949%201.png" alt="Image Description">
The activated DC then activate TC, when 2 additional co-stimulatory signals are present. The activated TC then activate BC with one additional co-stimulatory signal. The activated BC then produce their Ab, that are specific to the Ag originally presented on the DC.</li>
</ul>
<h2 id="organs-of-the-immune-system">Organs of the Immune system</h2>
<p>Distributed all over the body - fine distribution with lymph nodes
!<img src="/images/Pasted%20image%2020240508103739%201.png" alt="Image Description"></p>
<ul>
<li><strong>Primary/central lymphoid organs</strong> - production and maturation of immune cells e.g. bone marrow = BC maturation, thymus = TC maturation</li>
<li><strong>Secondary/peripheral organs</strong> - collect Ag to change from innate to adaptive immune response (lymph nodes, spleen and mucosa associated tissue)</li>
</ul>
<h3 id="lymph-node">Lymph node</h3>
<ul>
<li><strong>Lymphatic system</strong> - open system with one directional flow from extracellular matrix through the lymphatic system back into the blood  (20L /d).
!<img src="/images/Pasted%20image%2020240508112300%201.png" alt="Image Description"></li>
<li><strong>Lymph nodes</strong> enlarge when infection is ongoing, filtered foreign particles and cancer cells. Consists of <strong>Cortex</strong> and <strong>Medulla</strong>.
<ul>
<li><strong>Cortex</strong>
<ul>
<li>Outer cortex mainly contains BC - BC zone. Contains follicles, that produce and mature the BC in the germinal centers</li>
<li>Paracortex - TC zone, where APC enter and activate TC</li>
</ul>
</li>
<li><strong>Medulla</strong>
<ul>
<li>Contains strings of macrophages and Ab secreting cells (mature BC)</li>
<li>Naive TC and BC enter from blood vessels , guided by chemokines to the lymph node
!<img src="/images/Pasted%20image%2020240508112331%201.png" alt="Image Description"></li>
</ul>
</li>
<li><strong>Afferent and Efferent lymphatic vessels</strong> - DC enter through afferent vessels and leave together with other activated BC and TC through the efferent vessels. Activated lymph nodes re model and increase in size and normalize after immune response/infection is over.
!<img src="/images/Lymph%20node%201.png" alt="Image Description"></li>
</ul>
</li>
</ul>
<h3 id="spleen-milz">Spleen (milz)</h3>
<ul>
<li>Collects Ag and fights pathogens present in the bloodstream, without direct connection to the lymphatic system. Also degrades white and red blood cells.</li>
<li>Consists of <strong>Red and White pulp</strong>
<ul>
<li><strong>Red pulp</strong> - red blood cell disposal</li>
<li><strong>White pulp</strong> - Lymphoid tissue around the main blood vessels, that allows DC to present Ag and activate TC, BC in the <em>lymphoid follicles</em> present there.</li>
</ul>
</li>
</ul>
<h3 id="mucosa-associated-tissue-malt">Mucosa associated tissue (MALT)</h3>
<ul>
<li>Has tonsil, which has a high amount of lymphatic cells and crypt epithelium to increase surface area</li>
</ul>
<hr>
<h1 id="tcr-mhc-dc-cd---lecture-b">TCR MHC DC CD - Lecture B</h1>
<p>[[Lecture B (TCR, MHC, DC, CS)]]
!<img src="/images/Pasted%20image%2020240320085515%201.png" alt="Image Description"></p>
<h2 id="tcr">TCR</h2>
<ul>
<li>Present on TC ~ 30,000 identical copies present on its surface</li>
<li><em>Roughly know TCR and be able to compare to MHCII</em>!<img src="/images/Pasted%20image%2020240320090640%201.png" alt="Image Description"></li>
<li>$\alpha$ and $\beta$ chain connected via S-S, each comprising of a Variable region, that interacts with the peptide presented on MHCI/MHCII.</li>
<li>The Ag specific region in the Variable region is called <strong>Complementary determining region</strong>
TCR is also associated with multiple CD3 regions (Cluster of differentiation). The interaction of the ITAM motives between the TCR associated $\zeta$ chain and the transmembrane domains of the CD3 starts the activation of the TC.</li>
<li>The effector function of the TC does not depend on the TCR but on the cell-cell interaction. (Opposed to BC, where the  constant region of the BCR determines the effector function)
!<img src="/images/TCR%20activation%201.png" alt="Image Description">
(<em>Just remember, that the TCR is not sufficient and needs DC3 to be activated</em>)</li>
</ul>
<h3 id="different-cd">Different CD</h3>
<ul>
<li>Th cells - CD4+</li>
<li>cytotoxic TC - CD8+</li>
</ul>
<h3 id="tcr-diversity">TCR diversity</h3>
<ul>
<li>Variable region originates in 4 genes that can be rearranged on the level of the somatic DNA (permanent changes in the genetic code for one BC)</li>
<li>Three ways to generate variability - in the thymus
<ul>
<li><strong>Somatic recombination</strong> - several copies of the gene segments exist</li>
<li><strong>Junctional diversity</strong> - amount and combination of J regions in $\alpha$ and $\beta$ Chain varies</li>
<li>**Combination of different $V_{\alpha}$ and $V_{\beta}$
!<img src="/images/Pasted%20image%2020240320103109%201.png" alt="Image Description"></li>
</ul>
</li>
</ul>
<h2 id="major-histocompatibility-complex--mhc-on-apc">Major histocompatibility complex -MHC on APC</h2>
<ul>
<li>Glycoprotein, that carries peptide from processed Ag
<ul>
<li>MHCI - intracellular Ag (<em>except when cross-presentation</em>) [[1 Inbox/Archive/Immunotechnology/Summary for Exam#Cross presentation]]</li>
<li>MHCII - extracellular Ag</li>
</ul>
</li>
<li>Specific interaction with TCR resulting in:
<ul>
<li>Activation of cTC (cytotoxic TC) and killing of infected cells</li>
<li>Activation of macrophages or BC
Similar 3D structure but different subunits - also tissue dependent
!<img src="/images/MHCI%20and%20MHCII%201.png" alt="Image Description"></li>
</ul>
</li>
</ul>
<h3 id="mhci">MHCI</h3>
<ul>
<li>Presents to cTC (<strong>CD8+</strong>)</li>
<li>$\alpha$-chain has <strong>three domains</strong></li>
<li>Peptide cleft can hold <strong>8-10 AA</strong> long poly peptides
<ul>
<li>Binding cleft has <strong>high polymorphism</strong> with <strong>brought binding specificity</strong></li>
<li>Anchor-residues are holding the peptide in the grove
!<img src="/images/Pasted%20image%2020240320104709%201.png" alt="Image Description"></li>
</ul>
</li>
</ul>
<h3 id="mhcii">MHCII</h3>
<ul>
<li>Presents to Th (<strong>CD4+</strong>)</li>
<li>Binding cleft is made out of two domains - $\alpha_1$ and $\beta_1$, is wider and can hold <strong>13-17 AA</strong> long polypeptides
<ul>
<li>Binding cleft also has <strong>Anchor sequences</strong> and <strong>high polymorphism</strong>
!<img src="/images/Pasted%20image%2020240320105228%201.png" alt="Image Description">
(<em>remember the main differences  between them</em>)</li>
</ul>
</li>
</ul>
<h3 id="mhc-diversity">MHC diversity</h3>
<ol>
<li><strong>Polygeny</strong> - each individual carries multiple different MHC genes - that also have different binding properties</li>
<li><strong>Polymorphism</strong> - multiple alleles of the genes are present in the population and most individuals are <a href="https://en.wikipedia.org/wiki/Zygosity#:~:text=as%20%22pp%22.-,Heterozygous,refers%20to%20a%20specific%20genotype.">Heterozygote</a> for a given MHC gene (different variants of the gene on multiple alleles).
!<img src="/images/Pasted%20image%2020240320110309%201.png" alt="Image Description">
&ndash;&gt; estimated $4*10^{19}$ different combinations of hMHCI&amp;II with over 200 different genes</li>
</ol>
<ul>
<li>The variation is mainly found in the anchor sequence of the MHC genes.</li>
</ul>
<hr>
<h2 id="antigen-presentation">Antigen Presentation</h2>
<p>!<img src="/images/Pasted%20image%2020240320163432%201.png" alt="Image Description"></p>
<h2 id="apc">APC</h2>
<ul>
<li>All nucleated cells express MHCI and are potential APC, but only professional APC express MHCII (BC, DC and Macrophages)</li>
<li>The professional APC differ in their capability and mechanism to take up Ag and present it. Also their location within the body differs (<em>good to know</em>)</li>
</ul>
<p>!<img src="/images/Pasted%20image%2020240320164408%201.png" alt="Image Description">
!<img src="/images/Pasted%20image%2020240320164637%201.png" alt="Image Description"></p>
<h3 id="dc">DC</h3>
<ul>
<li>Bridge innate and adaptive immune system</li>
<li>Small in number but very potent</li>
<li>Migrate through lymphatic system to the nearest lymph node after activation and mature in the node.</li>
<li>Two major classes
<ul>
<li><strong>Plasmacytoid DC</strong> (CD123)
<ul>
<li>Sense viral infections and produce large amounts of interferons</li>
</ul>
</li>
<li><strong>Conventional DC</strong> (CD11c)
<ul>
<li>Most potent activators of naive TC</li>
</ul>
</li>
<li>Both express different <strong>pattern recognition receptors</strong> (PRR) like toll like receptors</li>
</ul>
</li>
</ul>
<h3 id="internalization-of-ag">Internalization of Ag</h3>
<ul>
<li><strong>Phagocytosis</strong> - receptor dependent
<ul>
<li>Large particles like pathogens, microorganisms</li>
<li>Uptake into phagosome and subsequent degradation
!<img src="/images/Pasted%20image%2020240320171343%201.png" alt="Image Description"></li>
</ul>
</li>
<li><strong>Endocytosis</strong> -receptor dependent
<ul>
<li>Soluble Ag</li>
<li>Detected by FcR (<em>so Ab dependent</em>) or PRR
!<img src="/images/Pasted%20image%2020240320171614%201.png" alt="Image Description"></li>
</ul>
</li>
<li><strong>Micropinocytosis</strong> - receptor independent
<ul>
<li>Small particles and extracellular fluid engulfed by invagination of membrane
!<img src="/images/Pasted%20image%2020240320171708%201.png" alt="Image Description"></li>
</ul>
</li>
</ul>
<h3 id="ag-processing">Ag processing</h3>
<ul>
<li>Two known pathways
<ul>
<li><strong>Cytosolic pathway</strong> - processes endogenous Ag and presentation on MHCI</li>
<li><strong>Endocytic pathway</strong> - processes exogenous Ag and presentation on MHCII</li>
</ul>
</li>
</ul>
<h3 id="mhc-restriction">MHC restriction</h3>
<ul>
<li>TCR only recognize and deliver their effector function, if the MHC, that they are interacting with is of the same type, they where primed by.</li>
<li>This can manifest in two different ways
<ul>
<li><strong>Direct interference</strong> by TCR-MHC interaction</li>
<li><strong>Incirect interference</strong> by interfering with the peptide
!<img src="/images/MHC%20restriction%201.png" alt="Image Description"></li>
</ul>
</li>
</ul>
<h2 id="ag-presentation">Ag presentation</h2>
<p>In the secondary lymphoid organs - tonsil, lymph nodes and spleen ([[1 Inbox/Archive/Immunotechnology/Summary for Exam#Organs of the Immune system]])!<img src="/images/Pasted%20image%2020240320174408%201.png" alt="Image Description">
(In this case the CD of the skin = Langerhans cells)</p>
<h3 id="tc">TC</h3>
<p>Naive TC enter the Lymph node from the blood through the <strong>high endothelial venules (HEV)</strong> and wait for Ag presentation to get activated and proliferate or leave again through the cortical sinus.
Their movement is driven by chemokine gradient.</p>
<h3 id="signals">Signals</h3>
<ol>
<li>Binding interaction of MHC and TCR</li>
<li>Costimulatory signal through <strong>CD28</strong></li>
<li><strong>Cytokines</strong> determine differentiation and effector function of TC
!<img src="/images/TC%20activation%201.png" alt="Image Description">
<em>If not all signals present - inactivation/deletion of the TC</em></li>
</ol>
<h3 id="tolerance">Tolerance</h3>
<p>Is induced to protect against autoimmune disease, when only CD28 signal is recognized by the TC.
!<img src="/images/Pasted%20image%2020240320175843%201.png" alt="Image Description"></p>
<h3 id="cross-presentation">Cross presentation</h3>
<p>Mechanism in DC, that allows the presentation of extracellular Ag on MHCI to activate cTC against extracellular pathogens.</p>
<h2 id="effector-tc">Effector TC</h2>
<p>Some activated TC transform directly into memory TC (rest effector TC). There are two different memory TC:</p>
<ul>
<li><strong>Central memory</strong> - not committed to a particular effector lineage</li>
<li><strong>Effector memory</strong> - rapidly mature into specific effector cells
<em>Know different types of helper cells and activation</em>
!<img src="/images/Pasted%20image%2020240320180535%201.png" alt="Image Description"></li>
</ul>
<h4 id="cd4-tc">CD4 TC</h4>
<ul>
<li>Activate BC and induce isotype switch
<ul>
<li>Th1 - INF-$\gamma$ -&gt;IgG</li>
<li>Th2 - IL-4 -&gt; IgE, IL-5,IL-13</li>
<li>Tfh - various also INF-$\gamma$</li>
</ul>
</li>
<li>Suppress TC activity
<ul>
<li>Treg</li>
</ul>
</li>
<li>Early stage of infection
<ul>
<li>Th17 - IL-17</li>
</ul>
</li>
</ul>
<p>!<img src="/images/Pasted%20image%2020240320180733%201.png" alt="Image Description"></p>
<hr>
<h1 id="b-cells-and-antibodies---lecture-c">B cells and Antibodies - Lecture C</h1>
<p>[[Lecture C (BC and AB)]]
!<img src="/images/Pasted%20image%2020240321112908%201.png" alt="Image Description"></p>
<h2 id="immoglobin">Immoglobin</h2>
<p>= Spechialized glycoproteins that are produced by Plasma B cells (fully developed B cells)</p>
<ul>
<li>Either called Ab - when solved in plasma or B cell receptor (BCR) when attached to the surface of the BC
<ul>
<li>Also different functions depending on this classification (Pathogen binding/maturation of BC)</li>
</ul>
</li>
</ul>
<h3 id="biological-effects-of-ab">Biological effects of Ab</h3>
<p>Protect against disease (more below and [[Lecture D (Effector functions)| here]]) by</p>
<ul>
<li>Binding of viral particles or toxins - preventing their effect on cells</li>
<li>Activation of the compliment system</li>
<li>Binding to pathogen surface and promotion of Opsonization (promotion of phagocytosis)</li>
<li>Binding of pathogen surface and recruit immune cells</li>
</ul>
<p>Ex. for usage: Rituximab = anti CD20 against lymphoma, Checkpoint inhibition</p>
<h3 id="ab-structure">Ab structure</h3>
<p>Similarities with [[Lecture B (TCR, MHC, DC, CS)#<em><strong>TCR</strong></em>|TCR]]</p>
<ul>
<li>Same structure for Ag binding site</li>
<li>But has two Ag binding sites and a Fc region, which enables different effector functions see [[Lecture D (Effector functions)| here]]
!<img src="/images/Pasted%20image%2020240321175115%201.png" alt="Image Description"></li>
<li>Ab consists of two identical heavy and light chains, both of which are connected via disulfide bonds (green and yellow)</li>
<li>It can also be divided into Variable (V) and Constant (C) region ( where C elicits the effector function and V enables specific Ag binding).
!<img src="/images/Pasted%20image%2020240321180144%201.png" alt="Image Description"></li>
</ul>
<h3 id="ab-function">Ab function</h3>
<ol>
<li>Ag binding via V region
<ul>
<li>Binding is specific to one epitope of the Ag and is non covalent.</li>
</ul>
</li>
<li>Effector function via C region
<ul>
<li>5 isotypes
<ul>
<li>IgG</li>
<li>IgM</li>
<li>IgD</li>
<li>IgA</li>
<li>IgE</li>
</ul>
</li>
<li>Each is associated with one specific effector function
!<img src="/images/Ab%20isotype%20comparison%201.png" alt="Image Description">
Each specific Ab is produced by one BC and the isotype is formed during the development of the BC</li>
</ul>
</li>
</ol>
<h2 id="bcr-structure">BCR structure</h2>
<p>Very similar to Ab (same gene locus but different splicing) -&gt; Membrane bound</p>
<h2 id="bc-maturation">BC maturation</h2>
<p>Part of the adaptive immune system derived from [[Pasted image 20240321181759 1.png| Common lymphoid progenitor]]. Must fulfill two requirements to mature:</p>
<ol>
<li><strong>Recognize appropriate Ag</strong> (non self Ag)</li>
<li><strong>Generate appropriate effector function</strong> (Ab with sufficient affinity)</li>
</ol>
<p>For 1 produce an Ab, that recognizes a novel compound, never encountered before (e.g. Covid protein)</p>
<ul>
<li>Creation of huge variety of BC, where only the ones carrying functional BCR survive</li>
<li>How to create this <strong>Variability</strong>
<ul>
<li>Ab/BCR contains <strong>hypervariable</strong> HV aka <strong>complementary determining region</strong> (CDR) and <strong>framework regions</strong> (FW) (<em>high and low variability respectively</em>)</li>
<li><strong>CDR</strong> = three regions on each Fragment variable Fv region (6 per Ab)</li>
</ul>
</li>
<li>How is Variability possible (&gt;$10^{11}$)? If one gene per Ab &gt;than human genome</li>
</ul>
<ol>
<li>**Somatic recombination
<ul>
<li>V region is encoded by V, D and J regions, that undergo <em>Irreversible</em> rearrangement during BC development &ndash;&gt; one specific V region
!<img src="/images/Pasted%20image%2020240322091346%201.png" alt="Image Description"></li>
</ul>
</li>
<li><strong>Junctional diversity</strong>
<ul>
<li>While V, D and J are combined, the process is imprecise leading to insertions and deletions
!<img src="/images/Pasted%20image%2020240322092949%201.png" alt="Image Description"></li>
</ul>
</li>
<li><strong>Combination of different VH and VL domains</strong>
<ul>
<li>See picture!<img src="/images/Pasted%20image%2020240322093132%201.png" alt="Image Description"></li>
</ul>
</li>
<li><strong>Somatic hypermutation</strong> in germinal centers ([[1 Inbox/Archive/Immunotechnology/Summary for Exam#Improve the affinity to Ag|below]])</li>
</ol>
<p>For 2  - avoiding the production of Ab against self Ag</p>
<ul>
<li>Eliminate all BC, that produce Ab against self Ag = <strong>Negative selection</strong> in bone marrow</li>
<li>When this doesn&rsquo;t work &ndash;&gt; autoimmunity
!<img src="/images/Pasted%20image%2020240322093516%201.png" alt="Image Description"></li>
<li>Also know when to produce Ab - Activation of BC via Th needs two signals
<ol>
<li>[[Pasted image 20240322093851 1.png|BCR-Ag]]  binding leads to stimulatory signal. And internalization of BCR and presentation of the [[Pasted image 20240322093957 1.png|Ag on MHCII]]</li>
<li>Co-stimulation by CD4+ Th cells that recognize the Ag on MHCII via CD40L. TCR has to recognize the same Ag <em>but not the same epitope</em> as the BCR.
!<img src="/images/B%20cell%20activation%201.png" alt="Image Description">
The Th cell is activated before by DC [[1 Inbox/Archive/Immunotechnology/Summary for Exam#Signals|see]] after activation, the Th start to produce CD40L, which enables the second signal for BC activation.</li>
</ol>
</li>
</ul>
<h3 id="improve-the-affinity-to-ag">Improve the affinity to Ag</h3>
<p><strong>Somatic hypermutation</strong> in [[Pasted image 20240322104203 1.png|germinal centers]] (temporal structure ~ 2w).</p>
<ol>
<li>Activated BC moves into a primary follicle and starts to proliferate</li>
<li>During proliferation Ab genes undergo mutation = somatic hypermutation</li>
<li>Quality control = positive selection by Follicular DC and Th cells to select for highest affinity candidates
<em>! Follicular DC are not DC</em> but look like them, they capture Ag and present it to BC and select BCR with high affinity.
<strong>Positive selection</strong> = only BC that bind Ag are able to be stimulated by Th, if they don&rsquo;t they undergo another round of somatic hypermutation or die.
!<img src="/images/B%20cell%20maturation%201.png" alt="Image Description"></li>
</ol>
<h2 id="ab-effector-function">Ab effector function</h2>
<p>Can be changed by <strong>Class</strong> and <strong>Isotype switch</strong> = C region is changed, while the V region stays the same. This is done to adapt to different pathogens.
Each Isotype is associated with different effector functions [[Lecture D (Effector functions)| see]] Lecture D</p>
<ul>
<li>All of the Constant regions are encoded separately, naive BC produce IgM and can change to IgD via RNA splicing (â‰  Class switch)</li>
<li>To produce another Isotype &ndash;&gt; Class switch = permanent via splicing out of different constant regions - regulated by cytokines  !<img src="/images/Pasted%20image%2020240322110736%201.png" alt="Image Description"></li>
<li>Although this is irreversible another switch to different Isotypes that are further down is still possible</li>
</ul>
<h3 id="pasted-image-20240322111408-1pngigg-vs-igm">[[Pasted image 20240322111408 1.png|IgG vs IgM]]</h3>
<ul>
<li>IgG has higher affinity but fewer binding sites(2 vs 10)</li>
<li>To compare the two their <strong>Avidity</strong> can be used = total binding strength depending on affinity and number of binding sites</li>
</ul>
<h2 id="ab-production-and-memory">Ab Production and memory</h2>
<p>Produce a high amount of Ab</p>
<ul>
<li>Therefore short-lived and long-lived plasma cells
<ul>
<li><strong>Short-lived</strong> plasma cells - from BC, that don&rsquo;t enter germinal center but where activated - produce mainly IgM, providing an immideate fast defense</li>
<li><strong>Long-lived</strong> plasma cells - undergo maturation in germinal center - produce mainly IgG in large quantity (can live for decades)</li>
</ul>
</li>
<li>Plasma cells reside in the bone marrow where they produce Ab.</li>
<li>The Long-lived plasma cells are already a kind of memory cell but always active and don&rsquo;t react on re-infection.</li>
<li>Therfore also <strong>memory BC</strong> = don&rsquo;t produce any Ab but are re-activated by exposure to the Ag, resulting in activation and rapid cell division !<img src="/images/Pasted%20image%2020240322112410%201.png" alt="Image Description"></li>
</ul>
<h2 id="summary">Summary</h2>
<p>!<img src="/images/Pasted%20image%2020240322113054%201.png" alt="Image Description"></p>
<hr>
<h1 id="effector-functions---lecture-d">Effector Functions - Lecture D</h1>
<p>[[Lecture D (Effector functions)]]</p>
<p>= Mechanism that is used to destroy and eliminate the Ag
[[Pasted image 20240322162327 1.png|Innate and adaptive immune response overview]]</p>
<h2 id="innate-immunity">Innate Immunity</h2>
<ul>
<li>Mainly phagocytosis by Macrophages and Neutrophils can distinguish between self and foreign with PPR (pathogen associated patterns)</li>
<li>Effector function of Phagocytosis are:
<ul>
<li>Uptake and destruction of Ag at low pH in the phagosome under addition of $H_2O_2$  or NO to kill Bacteria</li>
<li>Release of Chemokines and cytokines
!<img src="/images/Pasted%20image%2020240322162831%201.png" alt="Image Description"></li>
</ul>
</li>
</ul>
<h2 id="inflammation">Inflammation</h2>
<p>Induced during innate immune response and has three major functions:</p>
<ul>
<li>Attract other effector molecules and enable immune cells to come reach site of infection via increased vascular permeability</li>
<li>Create physical barrier via <strong>microvascular coagulation</strong> = cloth formation</li>
<li>Promotion of wound healing
!<img src="/images/Pasted%20image%2020240322164423%201.png" alt="Image Description"></li>
<li>IL-$\beta$ and TNF-$\alpha$ both
<ul>
<li>Activate vascular endothelium and enable movement of immune cells to site of infection</li>
<li>pro-inflammatory</li>
<li>cause fever</li>
</ul>
</li>
</ul>
<h2 id="complement-system">Complement system</h2>
<p>Complements the activity of <em>anti bacterial</em> Ab. Produced in the liver and induce a cascade - therefore it is important to keep them tightly regulated.
Generally three pathways:</p>
<ol>
<li><strong>Classic</strong> pathway - via [[Pasted image 20240324175750 1.png|Ag-Ab complexes]] on the pathogen surface</li>
<li><strong>Mannose binding lectin</strong> pathway - [[Pasted image 20240324180130 1.png|binds to pathogen surface]] = PAMP</li>
<li><strong>Alternative</strong> pathway - enhances the other two pathways by increasing the amount of C3 convertase
!<img src="/images/Pasted%20image%2020240324174237%201.png" alt="Image Description">
All pathways feed into the C3 convertase = key player in starting the cascade. Downstream:</li>
</ol>
<ul>
<li>C3a - release of inflammation mediators like histamine leading to <strong>Inflammation</strong></li>
<li>C3b - binds compliment receptor on the surface of the pathogen and promotes <strong>Opsonization</strong> or the formation of <strong>membrane attack complexes</strong> with other Complements.</li>
</ul>
<h2 id="production-of-soluble-mediators">Production of soluble mediators</h2>
<p>Like Interferons [[Pasted image 20240324181851 1.png|after viral infection]] - INF-$\alpha$ and INF-$\beta$</p>
<ul>
<li>A class of molecules, that increase the capacity of cells to increase the mount of MHCI&amp;II</li>
<li>This enables the ability to ID infected cells that are hijacked by the viral replication machinery</li>
<li>Also induce resistance to viral replication</li>
<li>And Activate
<ul>
<li>DC and Macrophages</li>
<li>NK cells to kill infected cells</li>
</ul>
</li>
</ul>
<h2 id="natural-killer-cells-nk">Natural killer cells (NK)</h2>
<ul>
<li>Kill cells infected by virus (just like cTC)
<ul>
<li>Using lytic granules
Detection of cells that are infected is possible, since these are not able to express as much MHCI in the presence of INF (see above). Their production capabilities is hijacked by the virus.
If the infection still persists after this, the adaptive immunity starts to kick in. ![[Attachments/Pasted image 20240324182538.png]]</li>
</ul>
</li>
</ul>
<h2 id="adaptive-immunity">Adaptive immunity</h2>
<h3 id="ab">Ab</h3>
<ul>
<li>Neutralize</li>
<li>Promote Opsonization</li>
<li>Activate complement (Classical pathway)
!<img src="/images/Pasted%20image%2020240324182745%201.png" alt="Image Description">
The effector function of the Ab is determined by the constant [[1 Inbox/Archive/Immunotechnology/Summary for Exam#Ab structure|Fc]] part of the Ab (<em>Important when choosing constant region for Ab treatment - most of the time IgGx depending on use case</em>)</li>
<li>IgG1 and IgG3 for Immune response</li>
<li>IgG2 and IgG4 for marking without immune response</li>
<li>IgM activates the compliment system well</li>
<li>IgE sensitizes mast cells
!<img src="/images/Pasted%20image%2020240324183018%201.png" alt="Image Description"></li>
</ul>
<h3 id="fcr">FCR</h3>
<p>The Fc region of an Ab has varying affinities for the Fc receptor (FCR)</p>
<ul>
<li>On Macrophages and mast cells, the FCR is spread out and inactive, once multiple Ab bind and the FCR&rsquo;s are in close proximity, cross link and Opsonization is promoted (done by IgE in the case of mast cells)![[Attachments/Pasted image 20240324183440.png]]</li>
<li>The FCR of NK cells (=CD16) is cross linked after the target cell is Identified by IgG -&gt; release of lytic granular and killing of target cell.!<img src="/images/Pasted%20image%2020240324183730%201.png" alt="Image Description"></li>
</ul>
<h3 id="tc-1">TC</h3>
<p>Three signals are necessary</p>
<ul>
<li>Ligation to MHC</li>
<li>Co-stimulation of CD28</li>
<li>Cytokines - secreted by APC and determine the TC type
!<img src="/images/Pasted%20image%2020240324184157%201.png" alt="Image Description">
Th and Treg also serete cytokines, that induce activity or proliferation of Macrophages or BC !<img src="/images/Pasted%20image%2020240324184519%201.png" alt="Image Description"></li>
<li>cTC are the main group of TC (CD8+) and their purpose is to induce a kill response utilizing toxins, that are stored in their granules.
<ul>
<li>Perforin -Induces pore in target cell</li>
<li>Fas ligand - when interacting with the Fas receptor triggers apoptosis</li>
</ul>
</li>
</ul>
<h2 id="summary-1">Summary</h2>
<p>!<img src="/images/Pasted%20image%2020240324185043%201.png" alt="Image Description"></p>
<hr>
<h1 id="antibodies---general">Antibodies - general</h1>
<p>[[1 Ab]]</p>
<h2 id="ab-source">Ab source</h2>
<ul>
<li>From <strong>Immunization reaction</strong> - polyclonal Ab&rsquo;s</li>
<li><strong>Monoclonal</strong> Ab (mAb)</li>
<li><strong>Recombinant</strong> Ab</li>
<li><strong>Combinatoric</strong> libraries</li>
</ul>
<blockquote>
<p>[!info] Ab sources under citeab.com</p></blockquote>
<h2 id="antisera">Antisera</h2>
<p>&ldquo;<a href="https://www.collinsdictionary.com/dictionary/english/antisera">Blood serum containing Ab against a specific Ag used to treat or provide immunity to a disease</a>&rdquo;</p>
<ul>
<li>Need for Ab with high affinity and specificity!<img src="/images/Pasted%20image%2020240325133147%201.png" alt="Image Description"></li>
<li>Immunogen vs Ag
<ul>
<li>Ag is recognized by Ab or TCR</li>
<li>Immunogen induces an immune response agains itself (not all Ag do this)
<ul>
<li>Therefore has to be displayable on MHC</li>
<li>If an Ab has to be designed against a small molecule e.g. a steroid -&gt; conjugation to a protein, that is able to induce an immune response</li>
</ul>
</li>
</ul>
</li>
</ul>
<h2 id="ab-design">Ab design</h2>
<p>To consider:</p>
<ul>
<li>Area of application - effector function? If so which one?</li>
<li>Where expressed - E.coli only allows for correct folding of scFv or Fab and non-human posttranslational modifications</li>
<li>Off-target effects on different tissue? - specificity</li>
<li>Polyclonal vs Monoclonal</li>
<li>Adjuvants = molecules, that stimulate the immune response - e.g. preserve the immunogen in the body longer
!<img src="/images/Pasted%20image%2020240325134240%201.png" alt="Image Description"></li>
</ul>
<h2 id="immunogen">Immunogen</h2>
<p>To consider:</p>
<ul>
<li>High purity!</li>
<li>Size -Increased immunity with increase in size
<ul>
<li>When to small -&gt; coupling to bigger peptide chain</li>
<li>Consider - choice of carrier, coupling point and degree of coupling all can have widely different results on the recognizability of the Immunogen
!<img src="/images/Pasted%20image%2020240325134622%201.png" alt="Image Description"></li>
</ul>
</li>
<li>Dose -small and large doses are not recognized
!<img src="/images/Pasted%20image%2020240325135416%201.png" alt="Image Description"></li>
<li>Rout of administration
<ul>
<li>Subcutaneous&gt;Intraperitoneal&gt;Intravenous</li>
<li>Also [[Pasted image 20240325135516 1.png|repeated dosing]] increases quality and quantity of Ab (also IgM -&gt; IgG)</li>
</ul>
</li>
<li>Adjuvant
<ul>
<li>More effective Ag presentation</li>
<li>Increasing Immunogenicity</li>
<li>Alteration of the isotype profile</li>
<li>&ldquo;Storage effect&rdquo; -&gt; prolonged immune response
!<img src="/images/Pasted%20image%2020240325135658%201.png" alt="Image Description"></li>
</ul>
</li>
<li>Choice of Animal</li>
</ul>
<h2 id="specificity">Specificity</h2>
<ul>
<li>Does Ab bind to target?</li>
<li>Is the target present?</li>
<li>Cross reactions?</li>
<li>Validate if usable for application</li>
</ul>
<h1 id="hybridoma-and-vaccination">Hybridoma and Vaccination</h1>
<p>[[2 Hybridoma and Vaccination]]</p>
<h2 id="hybridoma-technology">Hybridoma technology</h2>
<p>Ab that are found after Immunization are polyclonal</p>
<ul>
<li>Different Isotypes</li>
<li>Different affinities</li>
<li>Different properties
Monoclonal Ab would be better &ndash;&gt; Hybridoma technique. How to (<em>just know the 6 steps</em>):
!<img src="/images/Pasted%20image%2020240325142048%201.png" alt="Image Description">
!<img src="/images/Pasted%20image%2020240325142115%201.png" alt="Image Description"></li>
</ul>
<ol>
<li>Immunization
<ul>
<li>Immunogen into mouse -&gt; isolation of BC from spleen</li>
</ul>
</li>
<li>Immortalization
<ul>
<li>Fusion of immoral Myeloma cell with isolated BC&rsquo;s - PEG fusion or applied voltage
!<img src="/images/Pasted%20image%2020240325142255%201.png" alt="Image Description"></li>
<li>Cells produce Ab and divide indefinitely</li>
</ul>
</li>
<li>Selection in HAT medium
<ul>
<li>Use of media, which only allows cells to grow that are HGPRT+ and that are able to use &ldquo;Salvage pathway&rdquo; of cell division (utilizing degraded nucleotides for DNA synthesis). The other ne-novo pathway (Utilizing metabolites for nucleotide synthesis) is disabled by the presence of Aminopterin.</li>
<li>Normal BC are HGPRT+ but can&rsquo;t utilize the Salvage pathway</li>
<li>Myeloma cells are HGPRT- but can utilize the Salvage pathway</li>
<li>Only Hybridoma cells (HGPRT+ and Salvage) survive.</li>
</ul>
</li>
<li>Detection of Hybridoma, that has a promising BCR/Ab</li>
<li>Cloning based on the selected BCR/Ab
<ul>
<li>Clone selection 1 cell per well</li>
<li>Production of mAb in conventional cell culture</li>
</ul>
</li>
</ol>
<h2 id="vaccination">Vaccination</h2>
<p>Purpose is  to safely induce an immune response, that protects against Ag</p>
<ul>
<li>Ag either from pathogen or recombinant/synthetic</li>
<li>[[Pasted image 20240325143555 1.png|Generates memory]]</li>
<li>[[Pasted image 20240325143649 1.png|Most effective way to control infectious disease]]</li>
</ul>
<h3 id="active-vs-passive-vaccine">Active vs Passive vaccine</h3>
<ul>
<li>Active - induces immune response and creates <strong>long term protection</strong></li>
<li>Passive - transfer of immunologically active component like Ab to <strong>protect short term</strong>
Hard to say if vaccine prevents infection or improves response to pathogen.</li>
</ul>
<h3 id="generation-of-immune-response">Generation of immune response</h3>
<ul>
<li>Intra muscular (IM) injection uptake by DC</li>
<li>Activation of CD4+ and CD8+ TC in Lymph node&rsquo;s
<ul>
<li>Also creation of memory CD8+</li>
</ul>
</li>
<li>Activation of BC by CD4+ Th &ndash;&gt; plasma cells that produce Ab
<ul>
<li>Memory BC</li>
</ul>
</li>
</ul>
<h3 id="types-of-vaccines">Types of vaccines</h3>
<p>(<em>Don&rsquo;t need to know all of them but most important ones</em>)
!<img src="/images/Different%20vaccines%201%201.png" alt="Image Description">
!<img src="/images/Different%20vaccines%202%201.png" alt="Image Description"></p>
<h3 id="application">Application</h3>
<p>Effective vaccine must induce long lasting protection while being safe and inexpensive</p>
<ul>
<li>Allergy - immunotherapy
<ul>
<li>Injection of small doses, that gradually increase</li>
<li>Results in the production of neutralizing Ab, that block the Immunogen and stop subsequent allergic reaction</li>
<li>Shifts the TC response from Th2 to Th1</li>
</ul>
</li>
<li>Cancer
<ul>
<li>Against HBV - cancer inducing virus</li>
<li>Also personalized Therapeutic cancer vaccine - Autologous (using the patients immune cells) therapy producing tumor specific Ab</li>
</ul>
</li>
</ul>
<h3 id="herd-immunity">Herd immunity</h3>
<p>[[Pasted image 20240325145736 1.png|Herd immunity is]] archived when critical level of vaccination is reached. The protection is conferred to un-vaccinated individuals.</p>
<h2 id="summary-2">Summary</h2>
<p>!<img src="/images/Pasted%20image%2020240325143111%201.png" alt="Image Description"></p>
<hr>
<h1 id="affinity-and-kinetics">Affinity and Kinetics</h1>
<p>[[3 Affinity and Kinetics]]</p>
<h2 id="analysis-of-affinity">Analysis of affinity</h2>
<ul>
<li><strong>Affinity</strong> = binding <strong>strength</strong> of a ligand to <strong>one</strong> binding site on the Ab</li>
<li><strong>Kinetics</strong> = <strong>speed</strong> of the Ag-Ab complex formation</li>
<li><strong>Avidity</strong> = <strong>combined strength</strong> of interactions of Ag with both Ab binding sites
Equilibrium constant: $K_a = \frac{k_a}{k_b} = \frac{[AB]}{[A][B]}$ - gives us information about the affinity of the Ab. Higher often better</li>
</ul>
<h2 id="analysis-of-kinetics">Analysis of Kinetics</h2>
<ul>
<li>The individual association constant $k_a$ and dissociation constant $k_b$ are more important in the R&amp;D of an AB drug.
<ul>
<li>High $k_a$ /fast association of the complex for diagnostic Ab - Biosensor</li>
<li>Low $k_d$/slow dissociation of the complex for therapeutic Ab
!<img src="/images/Pasted%20image%2020240415081630%201.png" alt="Image Description"></li>
</ul>
</li>
</ul>
<h2 id="how-to-determine-affinity">How to determine affinity</h2>
<ul>
<li>Equilibrium dialysis</li>
<li>QCM-d</li>
<li>SPR</li>
<li>Isothermal titration calorimetry</li>
</ul>
<h3 id="equilibrium-dialysis">Equilibrium dialysis</h3>
<p>!<img src="/images/Pasted%20image%2020240415083345%201.png" alt="Image Description"></p>
<ul>
<li>Simple method but only suitable for small Ag</li>
<li>Can be used to [[Pasted image 20240415083702 1.png|calculate $K_a$]]</li>
</ul>
<h3 id="isothermal-titration-calorimetry-itc">Isothermal titration calorimetry (ITC)</h3>
<ul>
<li>[[Pasted image 20240415084052 1.png|Determines]] enthalpy and entropy of the binding interaction ($\delta G = \delta H - T \delta S$)</li>
</ul>
<h3 id="qcm-d">QCM-d</h3>
<p>Quartz Crystal Microbalance with Dissipation monitoring</p>
<ul>
<li>Surface sensitive, enables real time measurements (label free)
<ul>
<li>Alternating voltage is applied across the crystal</li>
<li>Crystal oscillates mass dependent <a href="https://en.wikipedia.org/wiki/Piezoelectricity">Piezoelectricity</a></li>
<li>When Protein binds to the crystal, the mass changes with it the frequency in which it vibrates</li>
</ul>
</li>
<li>Changes in frequency and energy dissipation are measured <strong>in real time</strong></li>
</ul>
<h3 id="surface-plasmon-response-spr">Surface Plasmon Response (SPR)</h3>
<ul>
<li>Real time measurement without need for label</li>
<li>Determines affinity and rate constant + entropy and enthalpy</li>
<li>Most commonly used method
The change in angle of the total reflection of a thin gold layer is measured. The thin layer is attached to an Ab and is slightly deformed upon Ag binding influencing the aforementioned angle.!<img src="/images/SPR%201.png" alt="Image Description"></li>
<li>The binding curves are recorded at different concentrations to derive the kinetic values.</li>
<li>Ab can be Immobilized Chemically, with Biotin, His tag</li>
</ul>
<p>Potential problems of SPR:</p>
<ul>
<li>Presence of more than one binding site per molecule</li>
<li>Diffusion of Ag in the solution could be uneven</li>
<li>Re-binding</li>
<li>Steric hinderances</li>
<li>Heterogenous Ag</li>
</ul>
<h3 id="ligand-tracer">Ligand Tracer</h3>
<ul>
<li>Used to determine the affinity of Ab to cell bound target
!<img src="/images/Pasted%20image%2020240415085753%201.png" alt="Image Description"></li>
</ul>
<h2 id="summary-3">Summary</h2>
<p>!<img src="/images/Pasted%20image%2020240415085810%201.png" alt="Image Description"></p>
<hr>
<h1 id="ab-based-application">Ab based Application</h1>
<p>[[4 Ab-based applications]]</p>
<ul>
<li>Employed everywhere - [[Pasted image 20240415102650 1.png|everyday life]] and research</li>
<li>Mostly Quantitate assays like Elisa (Enzyme kinked immunosorbent assay) !<img src="/images/Pasted%20image%2020240415102854%201.png" alt="Image Description"></li>
<li>They should be sensitive to low concentration of the target Ag in the presence of other analytes</li>
</ul>
<h2 id="common-detection-principles">Common detection principles</h2>
<ul>
<li>Radioactive isotopes</li>
<li><strong>Enzymes</strong> - mostly Horseradish peroxidase (HRP) or alkaline phosphatase\
<ul>
<li>Simple and gives visible feedback but smaller detection range than Fluorescence.</li>
</ul>
</li>
<li><strong>Fluorescence</strong> -high sensitivity and large dynamic range</li>
<li><strong>Chemiluminescence</strong></li>
<li><strong>Luminescence</strong></li>
<li>Polarity of light</li>
<li>SPR</li>
</ul>
<h3 id="radioactive-isotopes">Radioactive isotopes</h3>
<ul>
<li>Considered problematic
<ul>
<li>Instability of marker and molecule</li>
<li>Expensive and hard to work with
!<img src="/images/Pasted%20image%2020240415103613%201.png" alt="Image Description"></li>
</ul>
</li>
</ul>
<h2 id="competitive-vs-non-competitive-analysis">Competitive vs Non-competitive analysis</h2>
<h3 id="non-competitive">Non-competitive</h3>
<ul>
<li>Ag is captured by large number of binding sites before being detected - typically ELISA
<ul>
<li>Two Ab are used to enhance the specificity !<img src="/images/Pasted%20image%2020240415104217%201.png" alt="Image Description"></li>
<li>This also gives insight into the concentration of the Ag - higher concentration = stronger signal</li>
<li>High variability of the assay (e.g. in reagent concentration)</li>
<li>[[Pasted image 20240415104531 1.png|Multiplex analysis]] is also possible when bead based analysis is used</li>
<li>PROBLEM - small molecules are hard to detect</li>
<li>No need for pure Ag</li>
<li>The limit of detection is determined by the specificity of the interaction between both Ab and the Ag</li>
<li>Lower chance of cross reactivity since two Ab have to detect the same Ag</li>
</ul>
</li>
</ul>
<h3 id="competitive">Competitive</h3>
<ul>
<li>Labeled and non-labeled Ag&rsquo;s are added and both compete for limited amount of binding sites (low concentration of Ab).
!<img src="/images/Pasted%20image%2020240415104939%201.png" alt="Image Description">
<ul>
<li>This results in the [[Pasted image 20240415105139 1.png|inverse effect]] discussed above - higher concentration = weaker signal</li>
<li>Usable for low and high molecular weight Ag</li>
<li>Need for pure Ag</li>
<li>Limit of detection is dependent on the rate constant $K_A$ of the binding reaction of Ag-Ab</li>
<li>Chance of cross reactivity to similar Ag higher since only one Ab</li>
</ul>
</li>
</ul>
<h3 id="comparison">Comparison</h3>
<p>!<img src="/images/Pasted%20image%2020240415105430%201.png" alt="Image Description"></p>
<h2 id="heterogenous-vs-homogenous-analysis">Heterogenous vs Homogenous analysis</h2>
<p>Classification of weather a separation of soluble and the bound faction occurs - aka washing required or not.</p>
<ul>
<li><strong>Heterogenous</strong> - Requires separation</li>
<li><strong>Homogenous</strong> - Separation <strong>not</strong> required [[Pasted image 20240415105744 1.png|Example]]</li>
</ul>
<p>Example for Homogenous <em>non-competitive - I think</em> - AlphaScreen</p>
<ul>
<li>[[Pasted image 20240415110034 1.png|Analyte, First Ab and second Ab are added]]. First one on bead with label</li>
<li>[[Pasted image 20240415110108 1.png|Both bind]] on different epitpoes</li>
<li>Label for second Ab is added (enzyme)!<img src="/images/Pasted%20image%2020240415110156%201.png" alt="Image Description"></li>
<li>Both labels are exited and the signals are evaluated based on their proximity. Only double positive components are counted -no washing step needed.</li>
</ul>
<hr>
<h1 id="cell-based-immunological-methods">Cell based immunological methods</h1>
<p>[[5 Cell based methods]]</p>
<h2 id="common-assays">Common assays</h2>
<ul>
<li>Isolation of cells via:
<ul>
<li>Density gradient centrifugation</li>
<li>Magnetic beads</li>
<li>flow cytometry</li>
</ul>
</li>
<li>Viability/apoptosis assays</li>
<li>Microscopy
<ul>
<li>Cell counting</li>
<li>Immunofluorescence</li>
<li>Immunohistochemistry (IHC)</li>
</ul>
</li>
</ul>
<h3 id="isolation-from-whole-blood">Isolation from whole blood</h3>
<ul>
<li>Density gradient centrifugation [[Pasted image 20240415102019 1.png|gives]]:
<ul>
<li>Plasma (55%)</li>
<li>Buffy coat (&lt;1%)</li>
<li>Erythrocytes (45%)
The buffy coat contains most of the white blood cells and <a href="https://en.wikipedia.org/wiki/Platelet">platelets/thrombocytes</a>
[[Pasted image 20240415102134 1.png|Brake down]] of leucocytes in blood:</li>
</ul>
</li>
<li>TC  = 40-70%
<ul>
<li>CD4+ Th (<strong>CD3, CD4</strong>)</li>
<li>CD8+ cTC (<strong>CD3, CD8</strong>)</li>
</ul>
</li>
<li>BC (<strong>CD19</strong>, Ig+) = 5-20%</li>
<li>NK cells (<strong>CD56</strong>) &lt; 5%</li>
<li>Monocytes and Macrophages (<strong>CD14</strong>) = 5-20%</li>
<li>DC &lt;1%</li>
<li><a href="https://en.wikipedia.org/wiki/Basophil">Basophils</a> &lt;1%
High variation of BC, TC, Monocytes and Macrophages depending on doner and their condition.</li>
</ul>
<h3 id="isolation-with-magnetic-beads---macs">Isolation with magnetic beads - MACS</h3>
<p>MACS = small magnetic beads, that are biodegradable
Dynabeads = same thing but larger, but have to be removed before working with cells in culture</p>
<ul>
<li><strong>Direct labeling</strong> - Direct targeting of surface protein - with direct connection of Ab to the bead</li>
<li><strong>Indirect labeling</strong> - First labeling of the cell with primary Ab, then usage of secondary Ab connected to bead. Is used when no direct micro bead labeling is available.!<img src="/images/Pasted%20image%2020240415132600%201.png" alt="Image Description"></li>
<li>Further distinguishable into:
<ul>
<li><strong>Positive isolation</strong> - as above = labeling of the target cell (either direct or indirect)
<ul>
<li>Gives maximal purity</li>
<li>Reduces the amount of washing steps</li>
<li>But could activate the target cell</li>
</ul>
</li>
<li><strong>Untouched/negative selection</strong> = remove everything else
<ul>
<li>Target cell remains untouched</li>
<li>High viability</li>
<li>Easy removal of unwanted cells</li>
<li>low yield
MACS comparison:!<img src="/images/Pasted%20image%2020240415131900%201.png" alt="Image Description"></li>
</ul>
</li>
</ul>
</li>
</ul>
<h3 id="microscopy">Microscopy</h3>
<ul>
<li>Light microscope
<ul>
<li>[[Pasted image 20240415133348 1.png|Cell counting]] - Visible vs Dead cells (dead one are stained with e.g. triptan blue)</li>
</ul>
</li>
<li>IHC
<ul>
<li>[[Pasted image 20240415133645 1.png|Coloring]] for different cell types</li>
<li>Most commonly used is HRP (brown) and alkaline phosphatase (red or blue)</li>
<li>Or [[Pasted image 20240415133808 1.png|labeling with Ab]] (direct/indirect) - also amplification of the signal !<img src="/images/Pasted%20image%2020240415134015%201.png" alt="Image Description"></li>
</ul>
</li>
<li>Confocal microscopy
<ul>
<li>Computer aided - gives 3D image of the sample</li>
</ul>
</li>
<li>Expansion of IHC - high-multiplex tissue imaging
<ul>
<li>[[Pasted image 20240415134425 1.png|More markers]]
(<em>don&rsquo;t know the tech in detail, just know what exists</em>)</li>
</ul>
</li>
</ul>
<h2 id="characterization-of-lymphocyte-specificity-and-function">Characterization of lymphocyte specificity and function</h2>
<ul>
<li>Proliferation marker - high proliferation points to activation of the cell
<ul>
<li>3H-thymidine incorporation
<ul>
<li>After isolation of the cells 3H-Ty is added and incorporates into the DNA of dividing cells</li>
</ul>
</li>
<li>Cell trace staining
<ul>
<li>All cells are marked with dye and the intensity is measured after some time - less intensity = higher cell division. Also quantifiable with flow cytometry</li>
</ul>
</li>
</ul>
</li>
<li>Measure frequency of TC response - [[Pasted image 20240415135129 1.png|ELISPOT]] assay
<ul>
<li>Plate coated with Ab specific towards cytokine e.g. IL-4</li>
<li>Add cells TC/BC and wait</li>
<li>Wash the cells away again and add second Ab-label also specific to the same cytokine (sandwich Elisa) - measure signal.</li>
<li>With the known number of TC/BC the strength of activation can be measured.</li>
</ul>
</li>
</ul>
<h2 id="flow-cytometry">Flow Cytometry</h2>
<ul>
<li>Only works on suspended cells</li>
<li>Measure cell size, shape, markers, cytokine production&hellip;.
!<img src="/images/Pasted%20image%2020240415140039%201.png" alt="Image Description"></li>
<li>Forward scatter = size</li>
<li>Side scatter = granularity/internal complexity</li>
</ul>
<h3 id="tandem-dyes">Tandem dyes</h3>
<ul>
<li>Use of two dyes -acceptor and donor, that give a different signal when both are present on the same cell</li>
<li>This allows for the identification of multiple markers on the same cell</li>
</ul>
<h3 id="analysis-of-flow-cytometry">Analysis of Flow cytometry</h3>
<ul>
<li>Most commonly density plots, but also histograms are possible</li>
<li>Exercise
!<img src="/images/Pasted%20image%2020240415143048%201.png" alt="Image Description">
<ul>
<li>Solution
<ul>
<li>TC are CD3+, cTC are CD8+ - but CD8 can also be expressed on non TC</li>
<li>cTC are double positive (24%)</li>
<li>Not TC are CD3- and can be CD8+ (33.7%)</li>
<li>Th are CD3+ but CD8- (42.4%)</li>
</ul>
</li>
</ul>
</li>
</ul>
<h4 id="histogram">Histogram</h4>
<ul>
<li>Only shows one marker at a time !<img src="/images/Pasted%20image%2020240415143826%201.png" alt="Image Description"></li>
</ul>
<h3 id="viability">Viability</h3>
<ul>
<li>Annexin V staining -measures early apoptosis
<ul>
<li>When apoptosis starts the binding partner of annexin V, phosphatidylserine is expressed</li>
</ul>
</li>
<li>7-amino-actinomysin (7-AAD) staining - measures late state apoptosis
<ul>
<li>Binds to exposed Nucleic acid and can only do so when the plasma membrane is compromised.
!<img src="/images/Pasted%20image%2020240415144350%201.png" alt="Image Description"></li>
</ul>
</li>
</ul>
<h3 id="compensation">Compensation</h3>
<p>If multiple markers are combined - multiplex analysis, there is an [[Pasted image 20240502143805 1.png|overlap]] between the different staining&rsquo;s - potentially giving false positive signals.
Therefore the overlap has to be compensated for by e.g. use of single stain references.</p>
<ul>
<li>t-SNE compares the similarity of the signals and clusters cells according to this</li>
</ul>
<h4 id="spectral---next-level-of-multiplex">SPECTRAL - Next level of multiplex</h4>
<p>Allows to compensate for even [[Pasted image 20240415145207 1.png|overlapping spectra]]. A conventional cytometric analysis would only see one signal but SPECTRAL is able to se multiple (<em>how is not important</em>)!<img src="/images/Pasted%20image%2020240415145221%201.png" alt="Image Description"></p>
<h3 id="important-factors-in-flow-cytometry">Important factors in flow cytometry</h3>
<ul>
<li><strong>Compensation</strong> - for multiplex analysis</li>
<li><strong>Unspecific staining</strong> - Binding of the Fc region to the FCR on cells - producing a false positive
<ul>
<li>To avoid this - blocking of the FCR and Ab titration</li>
</ul>
</li>
<li><strong>Isotype controls</strong> - Estimate the amount of unspecific binding
<ul>
<li>Add Ab of the same isotype but non specific V region</li>
</ul>
</li>
<li><strong>Autofluorescence</strong> - Passive fluorescence of cells, even if no marker is present.</li>
</ul>
<h3 id="facs---cell-sorting">FACS - Cell sorting</h3>
<p>The drop containing one cell is charged and then moved in a magnetic field after detection. This yields high purity samples.</p>
<h3 id="application-1">Application</h3>
<ul>
<li>Analysis of <strong>cytokine production</strong> - of Leukocytes
<ul>
<li>Activated cells are fixated and the export of cytokines form the ER is suppressed</li>
<li>Cell is lysed and the cytokines are stained with Ab</li>
<li>This yields the [[Pasted image 20240415145811 1.png|cytokine profile]] of individual cells</li>
</ul>
</li>
<li>Analysis of <strong>secreted cytokines</strong> - Cytokine Bead Array (CBA) assay
<ul>
<li>Labeled beads are added into sample and collect the cytokine</li>
<li>Additional staining with second Ab, that is also specific towards the cytokine
<ul>
<li>Easy to use, multiplex possible but expensive</li>
</ul>
</li>
</ul>
</li>
<li>More advanced cytokine analysis -Luminex multiplex assay also a CBA
<ul>
<li>Same  principle as above but higher capacity and complexity</li>
<li>Requires specialized machine</li>
</ul>
</li>
<li>Measure <strong>proliferation</strong> - BrdU (synthetic nucleotide analogous to thymidine)
<ul>
<li>BrdU is incorporated into newly synthesized DNA and can be measured by Ab staining.</li>
</ul>
</li>
<li>Identification of <strong>TCR specificity</strong>
<ul>
<li>MHCI with Ag is used to isolate specific TC</li>
</ul>
</li>
</ul>
<h2 id="summary-4">Summary</h2>
<p>!<img src="/images/Pasted%20image%2020240415150522%201.png" alt="Image Description"></p>
<hr>
<h1 id="antibody-techniques">Antibody techniques</h1>
<p>[[6 Ab techniques]]</p>
<h2 id="precipitation">Precipitation</h2>
<ul>
<li>Ag-Ab complex producers insoluble precipitate
<ul>
<li>Simple and cheap</li>
<li>Depends on Ab and Ag valence = amount of Ab that can bind Ag</li>
<li>Start with excess of Ab and titrate Ag until [[Pasted image 20240519100720 1.png|Equilibrium]] is reached 	  !<img src="/images/Pasted%20image%2020240502132134%201.png" alt="Image Description"></li>
<li>If there is to much Ag, the [[Pasted image 20240519100720 1.png|Equilibrium]] structure disintegrates again and each Ab binds two Ag (solubility$\uparrow$)</li>
<li><strong>Valence</strong>
<ul>
<li>Valence =&lt; no. of epitopes available for the Ab to bind		  !<img src="/images/Pasted%20image%2020240502133244%201.png" alt="Image Description"></li>
<li>Influenced by Steric hindrance and the amount of Ab that bind the Ag/that are used up</li>
<li>Polyclonal vs Monoclonal</li>
<li>Small vs large Ag
<ul>
<li>For small - less epitopes are available for Ab to bind</li>
</ul>
</li>
</ul>
</li>
<li>Exercise Valency
<ul>
<li>!<img src="/images/Pasted%20image%2020240502133535%201.png" alt="Image Description">
<ol>
<li>Hapten is very small and would disappear i the binding site of the mAb - no precipitation</li>
<li>Same as above - hapten too small</li>
<li>If the same epitope is repeated multiple times on the Ag precipitation possible</li>
<li>Ideal situation - highest probability for precipitation</li>
</ol>
</li>
</ul>
</li>
</ul>
</li>
</ul>
<h3 id="single-radial-immunodiffusion">Single radial immunodiffusion</h3>
<ul>
<li>Ab in gel, sample is added
<ul>
<li>Sample [[Pasted image 20240502134313 1.png|diffuses out]] into the gel and participates</li>
<li>The higher the Ag concentration, the bigger the radius of the circle</li>
<li>With standard curve - Ag concentration</li>
</ul>
</li>
</ul>
<h3 id="rocket-electrophoresis">Rocket electrophoresis</h3>
<ul>
<li>Same principle as above but electrophoresis is employed to direct the spread of the Ag. pH is selected, so that the Ab do not move in the gel
<ul>
<li>AUC/surface area is equal to the amount of Ag</li>
<li>Increased resolution and easier quantification than single radial immunodiffusion</li>
</ul>
</li>
</ul>
<h2 id="immunochromatography">Immunochromatography</h2>
<ul>
<li>Purification of Ab or other proteins using affinity interactions</li>
<li>Can be used as negative selection, to assure that the Ab doesn&rsquo;t bind to other similar targets (no off target interactions). E.g. when doing quality control for the secondary Ab employed in elisa</li>
</ul>
<h3 id="ag-chromatography-ag-fixated">Ag chromatography (Ag fixated)</h3>
<ul>
<li>Ab mix is added into chromatography - specific ones stick and are later released by pH change (after washing)
!<img src="/images/Pasted%20image%2020240502134749%201.png" alt="Image Description"></li>
<li>Issues
<ul>
<li>Non specific binding of the Abs</li>
<li>Loss of some Ab</li>
<li>Elution technique could change the Ab structure</li>
</ul>
</li>
</ul>
<h3 id="protein-a-and-b-column">Protein A and B column</h3>
<ul>
<li>Protein A = high affinity to Fc of IgG Protein B also high affinity specific to Ab</li>
<li>Affinity to different Fc regions is utilized</li>
<li>Allows for milder conditions</li>
<li>Gives wide array of Ab, that are not specific towards one AgNot usable for all Isotypes</li>
</ul>
<h3 id="purification-with-ab-coupled-to-magnetic-beads">Purification with Ab coupled to magnetic beads</h3>
<ul>
<li>Use His tag to purify under mild conditions !<img src="/images/Pasted%20image%2020240502140120%201.png" alt="Image Description"></li>
</ul>
<h2 id="immunoblotting-techniques">Immunoblotting techniques</h2>
<ul>
<li>[[Western Blot 1.png|Western blot]]
<ul>
<li>ID defined protein after separation un gel - SDS page</li>
<li>Transfer into nitrocellulose shear and color with Ab</li>
<li>Can also be used after collecting Ag with [[Pasted image 20240502142047 1.png|magnetic beads/immunoprecipitation]]</li>
</ul>
</li>
</ul>
<h2 id="agglutination-techniques">Agglutination techniques</h2>
<ul>
<li>Used for blood group determination by clumping of particles
<ul>
<li>Ab agglutinates Ag coated particles
!<img src="/images/Pasted%20image%2020240502142338%201.png" alt="Image Description"></li>
<li>AB ideal recipient</li>
<li>O ideal donor</li>
</ul>
</li>
</ul>
<hr>
<h1 id="phage-display">Phage display</h1>
<p>[[7 Phage display]] [[11 Phage display]]</p>
<ul>
<li>
<p>Gives Ag specific scFv from a large collection of molecules</p>
</li>
<li>
<p>[[Pasted image 20240506131924 1.png|Inspired by immune system]]</p>
</li>
<li>
<p>Different approaches for the production of Ab</p>
<ul>
<li><strong>Instructionist</strong> approach - design protein and optimize form scratch (might be future with AI)</li>
<li><strong>Selectionist</strong> approach - select Ab with desired function</li>
</ul>
</li>
</ul>
<h2 id="ab-library">Ab library</h2>
<ul>
<li>Contains big number of Ab</li>
<li>Created in different ways
<ul>
<li>BC genes from either immunized or non-immune subjects</li>
<li>Synthetic genes / introduction of mutations	  !<img src="/images/Pasted%20image%2020240506132625%201.png" alt="Image Description"></li>
</ul>
</li>
<li>How to select useful Ab? - analogues to BC the phage displays Ab fragments on the surface and the phages with highest affinity are selected.</li>
<li>Has to have big size but also high variability and functionality of the Ab (correctly folded)
<ul>
<li>Design of new fragments - recombine the 6 complementary determining regions present on each scFv !<img src="/images/Pasted%20image%2020240514145510%201.png" alt="Image Description"></li>
</ul>
</li>
</ul>
<h2 id="phage">Phage</h2>
<ul>
<li>Bacteria specific virus mostly</li>
<li>long, thin and flexible - circular ssDNA genome</li>
<li>Phage binds to the F-pilus of E.coli (used for horizontal gene transfer) and infects it.
<ul>
<li>Non lytic</li>
<li>only one time infection, since the F-pilus is removed after infection (no super-infection)	  !<img src="/images/Pasted%20image%2020240506133324%201.png" alt="Image Description"></li>
</ul>
</li>
<li>Can be modified to display foreign peptides on its surface (limited space - scFv) usuallt on <strong>PIII</strong></li>
<li>scFv ~ 25kDa, Fab - 50 kDa (scFv can be filtered out by kidney)!<img src="/images/Pasted%20image%2020240514143248%201.png" alt="Image Description"></li>
</ul>
<h2 id="phage-rescue">Phage rescue</h2>
<ul>
<li><strong>Phagemid</strong> is a hybrid of Phage and plasmid vectors
<ul>
<li>Can&rsquo;t produce potent phage particles</li>
</ul>
</li>
<li>A <strong>helper-phage</strong> is used to produce all other Phage proteins</li>
</ul>
<h2 id="phage-display-cycle">Phage display cycle</h2>
<ul>
<li>Affinity chromatography
<ul>
<li>Immobilized Ag</li>
<li>Phagemids are added</li>
<li>Non- binding ones are removed</li>
<li>Binders are replicated in E.coli with the helper phages</li>
<li>Repeat cycle for affinity maturation with new sub libraries ([[Pasted image 20240514152830 1.png|in each the frequency of the specific phagemid is increased]])</li>
</ul>
</li>
<li>Depending on the use case many modifications can be made
<ul>
<li>Different selection - competing binders, heating, different washing and elution conditions</li>
<li>Use on cells</li>
<li>Display on Ribosomes, yeast, cells ([[Pasted image 20240514151614 1.png|less efficient]])</li>
</ul>
</li>
</ul>
<h3 id="selection-for">Selection for</h3>
<ul>
<li>Species specificity (human vs mouse) and Specificity to the Ag (add competing Ag during selection)</li>
<li>Affinity (harsher washing steps)</li>
<li>Stability (heating, other chemicals)</li>
<li>Cataltysis</li>
</ul>
<h2 id="analysis-of-the-selected-binders">Analysis of the selected binders</h2>
<ul>
<li>Elisa - easily automated</li>
<li>SPR</li>
</ul>
<h2 id="optimize-the-abget-better-ones">Optimize the Ab/get better ones</h2>
<ul>
<li>Mutate genes encoding the binding region</li>
<li>New selection rounds
!<img src="/images/Pasted%20image%2020240506135319%201.png" alt="Image Description"></li>
</ul>
<h2 id="application-2">Application</h2>
<ul>
<li>mAb
<ul>
<li>Modification and improvement</li>
</ul>
</li>
<li>Study Immune response in patients
<ul>
<li>Allergy</li>
<li>Cancer</li>
<li>Viral infection</li>
</ul>
</li>
<li>Study protein-protein interactions</li>
</ul>
<h2 id="summary-5">Summary</h2>
<p>!<img src="/images/Pasted%20image%2020240514153458%201.png" alt="Image Description"></p>
<hr>
<h1 id="recombinant-antibodies">Recombinant Antibodies</h1>
<p>[[8 Recombinant Ab]]</p>
<h2 id="why-use-recombinant-ab">Why use Recombinant Ab?</h2>
<ul>
<li>Rescue [[Pasted image 20240506141633 1.png|specificity and use of appropriate production cell]] line</li>
<li>Humanization</li>
<li>Design of effector function</li>
<li>Functionalization of scFv form phage display</li>
<li>Ab generated form transcript of isolated cells</li>
</ul>
<h2 id="humanization">Humanization</h2>
<ul>
<li>Chimeric Ab - mouse V region and human C region</li>
<li>Complementary defining region (CDR) grafted Ab - mouse CDR in human Ab
<ul>
<li>Problem of Immunogenicity is not completely removed and CDR regions can miss fold when recombined</li>
</ul>
</li>
<li>Humanization through guided selection - translate specific mouse Ab into corresponding human fragments from library!<img src="/images/Pasted%20image%2020240506142453%201.png" alt="Image Description">!<img src="/images/Pasted%20image%2020240506142506%201.png" alt="Image Description"></li>
</ul>
<h2 id="effector-function">Effector function</h2>
<ul>
<li>Change C region !<img src="/images/Pasted%20image%2020240506142615%201.png" alt="Image Description"></li>
<li>Also ADC (Ab drug conjugates)</li>
<li>Or conjugation with enzymes, cytokines or radioactive label</li>
<li>CAR TC - Harvested TC are genetically modified so that they are specific against a tumor of the patient</li>
<li>Bi-speric Ab - Tumor cell on one side and cTC on the other (close proximity induces kill of tumor cell)</li>
<li>FcR neonatal binding - prolonged half life of the Ab</li>
</ul>
<h2 id="production">Production</h2>
<ul>
<li>In vitro - small scale but no glycosylation</li>
<li>Ecoli - limited size (scFv, Fab) and no glycosylation</li>
<li>Yeast - glycosylation but non-human</li>
<li>CHO - good but expensive</li>
<li>Insect cells -high productivity but different glycosylation</li>
<li>Animal and plants - edible product, different glycosylation in plants and GMO regulatory problems
!<img src="/images/Pasted%20image%2020240506143511%201.png" alt="Image Description"></li>
</ul>
<h3 id="carbohydrates-in-ab">Carbohydrates in Ab</h3>
<ul>
<li>Important for the structure and function of the constant region
<ul>
<li>O-linked carbohydrates - uncommon on ser and thr</li>
<li>N-linked carbohydrates - Asn-X-Ser/Thr motive</li>
</ul>
</li>
<li>Can also influence the V region especially after somatic hyper mutation</li>
<li>Problem
<ul>
<li>Make it difficult to characterize the Ab</li>
<li>Therapeutic side effects
<ul>
<li>Patients with allergy against $\alpha$-gal-carbohydrates (induced by tick bites) also show allergic response against carbohydrates in Cetuximab - can induce allergic shock</li>
</ul>
</li>
</ul>
</li>
</ul>
<hr>
<h1 id="allergy">Allergy</h1>
<p>[[9 Allergy]]</p>
<ul>
<li>On the rise - most common chronic disease in EU
<ul>
<li><strong>Allergic contact dermatitis</strong> affects about 20% of European adult population</li>
</ul>
</li>
</ul>
<h2 id="hypersensitivity">Hypersensitivity</h2>
<ul>
<li>Four types (<em>focus an 1 and 4</em>)
<ol>
<li><strong>IgE</strong> mediated
<ul>
<li>Typically proteins like pollen or animal</li>
<li>short initiation of 2-30 min</li>
<li><strong>Mast cells</strong> are effectors
<ul>
<li>Activated when clustering of <strong>FC$\epsilon$RI</strong> by IgE !<img src="/images/Pasted%20image%2020240519142356%201.png" alt="Image Description"></li>
</ul>
</li>
<li>Symptoms are itching eyes, runny nose, can also be severe</li>
</ul>
</li>
<li><strong>IgG</strong> mediated against <strong>surface</strong> or <strong>matrix</strong> associated Ag like Penicillin
<ul>
<li>medium initiation 5-8 h</li>
<li>Phagocytes and NK cells</li>
<li>Symptoms
<ul>
<li>Anemia in the case of penicillin</li>
<li>Uricaria - chronic rashes and swelling often Immune response against Fc$\epsilon$RI subunit or IgE</li>
</ul>
</li>
</ul>
</li>
<li><strong>IgG</strong> towards <strong>soluble Ag</strong> - formation of immune complexes
<ul>
<li>medium initiation 2-8 h</li>
<li>Phagocytic effector mechanism</li>
<li>Ex: Drugs containing particles from other species or some small molecule drugs (SMD)</li>
<li>Causes deposition of Ag-Ab aggregates		  !<img src="/images/Pasted%20image%2020240519143340%201.png" alt="Image Description"></li>
</ul>
</li>
<li><strong>TC</strong> mediated
<ul>
<li>long initiation 1-3d</li>
<li>Soluble or cell associated Ag</li>
<li>Symptoms:
<ul>
<li>Rashes</li>
<li>Allergic contact dermatitis (ACD)</li>
</ul>
</li>
<li>About 4,000 known chemicals - fragrant, latex, Ni,&hellip;</li>
<li>Langerhans cells (DC of the skin) take up Ag and activate Th cells - secrete pro inflammatory cytokines -&gt; inflammation!<img src="/images/Pasted%20image%2020240519143812%201.png" alt="Image Description">
<em>New type of classification</em></li>
</ul>
</li>
</ol>
</li>
<li>important &lsquo;Allergy&rsquo; = Type2/IgE</li>
</ul>
<h3 id="definitions-hypersensitivity">Definitions (Hypersensitivity)</h3>
<ul>
<li><strong>Atopy</strong> - generic predisposition to develop allergy</li>
<li>Allergy - Immune response against harmless allergen</li>
<li>Allergen - Immunogen causing allergy</li>
</ul>
<h2 id="closer-look-at-hypersensitivity-type-1-and-4">Closer look at Hypersensitivity type 1 and 4</h2>
<h3 id="1-sensitization-effector-phase-and-late-stage">1 Sensitization, Effector phase and Late stage</h3>
<p>!<img src="/images/Pasted%20image%2020240519144419%201.png" alt="Image Description">
[[valenta2002 1.pdf]]</p>
<ul>
<li>Initial sensitization</li>
<li>Effector phase
<ul>
<li>Inflammatory mediators (histamine&hellip;) are released</li>
<li>Increased mucus secretion, blood flow</li>
<li>Swelling, congestion, coughing, &hellip;</li>
</ul>
</li>
<li>Effector phase
<ul>
<li>Difficult to predict
!<img src="/images/Pasted%20image%2020240519144621%201.png" alt="Image Description"></li>
</ul>
</li>
</ul>
<h3 id="type-4-sensitization-and-elicitation-phase">Type 4 sensitization and elicitation phase</h3>
<p>!<img src="/images/Pasted%20image%2020240508135342%201.png" alt="Image Description">!<img src="/images/Pasted%20image%2020240508135514%201.png" alt="Image Description"></p>
<h2 id="why-does-allergic-contact-dermatitis-exist">Why does Allergic contact Dermatitis exist?</h2>
<p>Hypothesis is that ACD is useful to identify danger associated signals, that get released when cells are dying (recognized by pattern recognition receptor PRR).</p>
<ul>
<li>Activated by e.g. ROS or Ni</li>
</ul>
<h2 id="effector-cells---mast-cells">Effector cells - mast cells</h2>
<ul>
<li>Different effector function [[Pasted image 20240508140005 1.png|depending on the tissue]] they reside in</li>
<li>After activation they release granules that can have different contents !<img src="/images/Pasted%20image%2020240508140126%201.png" alt="Image Description"></li>
</ul>
<h2 id="effector-cells---basophils">Effector cells - Basophils</h2>
<ul>
<li>Found in circulation</li>
<li>Express Fc$\epsilon$RI = IgE receptor</li>
<li>Produce many mediators, that can cause tissue damage and enhance inflammation response</li>
</ul>
<h2 id="effector-cells-th2">Effector cells Th2</h2>
<ul>
<li>Cytokines involved in allergy
<ul>
<li>IL-4, IL-13 - isotype switch to IgE</li>
<li>IL-9 - mast cell growth and development</li>
<li>IL-5 regulate influx of eosinophils</li>
</ul>
</li>
</ul>
<h2 id="optimal-allergen">&lsquo;Optimal&rsquo; allergen</h2>
<ul>
<li>Low dose</li>
<li>Small</li>
<li>High solubility</li>
<li>High stability</li>
<li>Presentable on MHCII (either peptide or protein association)</li>
<li>Structural similarities between known allergens
<ul>
<li>Apple and Birch - most sensitization happens by birch and people allergic to birch also often develop allergies against apple</li>
</ul>
</li>
</ul>
<h2 id="why-develop-an-allergy">Why develop an allergy?</h2>
<ul>
<li>Genetic factors
<ul>
<li>TCR, MHCII, FC$\epsilon$R, IL-4, pattern recognition receptor, &hellip;</li>
</ul>
</li>
<li>Environmental factors
<ul>
<li>Higher prevalence in city and among rich population</li>
</ul>
</li>
<li>Pollution - hard to prove
<ul>
<li>Industrial pollution and diesel fumes</li>
</ul>
</li>
<li>Hygiene
<ul>
<li>To sterile environments decrease early exposure</li>
</ul>
</li>
<li>Natural bacterial flora
<ul>
<li>Micro biome gets disrupted, when antibiotics are given early</li>
</ul>
</li>
</ul>
<h2 id="diagnosis">Diagnosis</h2>
<ul>
<li>Skin prick</li>
<li>Patient history</li>
<li>limited - false positives and false negatives are common</li>
</ul>
<h2 id="treatment">Treatment</h2>
<ul>
<li>Anti histamines and cortical steroids reduce syptoms</li>
<li>Inhibit the binding of IgE to mast cell Fc$\epsilon$R !<img src="/images/Pasted%20image%2020240508145634%201.png" alt="Image Description"></li>
<li>Desensitisation therapy - create Ag specific IgG, that remove the Ag before inflammatory response starts = switch from Th2 (IgE producing) to Th1 (IgG producing)
!<img src="/images/Pasted%20image%2020240508145846%201.png" alt="Image Description">!<img src="/images/Pasted%20image%2020240508145904%201.png" alt="Image Description"></li>
</ul>
<h2 id="summary-6">Summary</h2>
<p>!<img src="/images/Pasted%20image%2020240508145921%201.png" alt="Image Description"></p>
<hr>
<h1 id="advanced-detection-principles">Advanced detection principles</h1>
<p>[[10 Advanced detection principles]]</p>
<h2 id="biomarkers">Biomarkers</h2>
<p>= Characteristic, that can be <em>objectively</em> measured and is an indicator of biological processes</p>
<ul>
<li>Measurable on different levels from Genome to metabolites</li>
<li>Gives insight into e.g.
<ul>
<li>Response to treatment</li>
<li>Disease diagnosis, progression and prognosis</li>
<li>Categorization of patients</li>
</ul>
</li>
<li>Challenge: A lot of Biomarkers are discovered but only a view are developed into usable pattents
<ul>
<li>Low amounts of well documented patient samples</li>
<li>Challenging biomarker origins e.g. Brain</li>
<li>Produced biomarkers are often either sensitive or specific but seldom both</li>
<li>Markers can be quite rare</li>
</ul>
</li>
</ul>
<h2 id="ab-ag-biding">Ab-Ag biding</h2>
<ul>
<li>Western blot</li>
<li>ELISA</li>
<li>Ab micro-arrays</li>
<li>in situ methodes
!<img src="/images/Pasted%20image%2020240514132446%201.png" alt="Image Description"> <strong>Important</strong>: second (right) Ab $\neq$ secondary Ab (middle). Secondary Ab detects primary Ab. Second Ab = First Ab</li>
</ul>
<h3 id="labeling">Labeling</h3>
<ul>
<li>Conjugation
!<img src="/images/Pasted%20image%2020240514132723%201.png" alt="Image Description">
<ul>
<li>Streptavidin-Biotin Systems
<ul>
<li>Ab carry biotin (Vit H)</li>
<li>Doesn&rsquo;t change Ab properties and seldom interferes with binding</li>
<li>Streptavidin binds biotin fast and forms one of the most stable bound known in Biology</li>
</ul>
</li>
</ul>
</li>
</ul>
<h3 id="detection">Detection</h3>
<ul>
<li>Radioactive isotopes</li>
<li>Enzymes - HRP or Alkaline phosphatase</li>
<li>Flurophores - FITC
!<img src="/images/Pasted%20image%2020240514133202%201.png" alt="Image Description"></li>
</ul>
<h2 id="signal-amplification">Signal amplification</h2>
<h3 id="tyramide-signal-amplification-tsa">Tyramide signal amplification (TSA)</h3>
<p>HRP is used to activate Tyramide carrying a fluorochrome. The active Tyramide then attaches to tyr side chains on the Ab.
!<img src="/images/Pasted%20image%2020240514133544%201.png" alt="Image Description"></p>
<h3 id="proximity-ligation-assays-pla">Proximity ligation assays (PLA)</h3>
<p>Combination of Ab detection with PCR amplification</p>
<ul>
<li>Target protein is detected with two different Ab that bind to close epitopes</li>
<li>Ab coupled ssDNA</li>
<li>Connector is added and binds if the Ab are close enough together</li>
<li>Amplification of the chain in PCR</li>
<li>Detection of the produced ds DNA (e.g. PCR)
!<img src="/images/Pasted%20image%2020240514133825%201.png" alt="Image Description"></li>
<li>Different variation in situ PLA rolling circle amplification (<em>This is complicated method, if in exam question for essay - simple and robust is better</em>)!<img src="/images/Pasted%20image%2020240514133932%201.png" alt="Image Description"></li>
</ul>
<h2 id="multiplexing">Multiplexing</h2>
<p>Rule of thumb:</p>
<ul>
<li>Specificity (detect true negative/don&rsquo;t have biomarker) $\uparrow$ often = Sensitivity (detect true positive/ have biomarker) $\downarrow$</li>
<li>Can be circumvented when specific and sensitive markers are used together</li>
</ul>
<h3 id="micro-array">Micro array</h3>
<p>= Multiplex ELISA in a single assay</p>
<ul>
<li>IMMray technology
<ul>
<li>Different scFv in each well of the micro array plate catch blood sample, that is biotinylated for detection</li>
<li>Streptavidin-fluorochrome is added after washing step</li>
<li>Combined signal enables disease diagnosis
!<img src="/images/IMMray%201.png" alt="Image Description"></li>
</ul>
</li>
</ul>
<h2 id="summary-7">Summary</h2>
<p>!<img src="/images/Pasted%20image%2020240514134913%201.png" alt="Image Description"></p>
<hr>

</article>

                
    
    
        Â©2025 Johannes Roylands. Made with <a href="https://gohugo.io/">hugo</a>
    


            </div>
        </main>
    </body>
</html>
